Search Results - "QUAAS, A"

The sharp exponent in the study of the nonlocal Hénon equation in $${\mathbb {R}}^{N}$$: a Liouville theorem and an existence result by Barrios, B., Quaas, A.

Get full text

Recurrence after primary salivary gland carcinoma: Frequency, survival, and risk factors by Nachtsheim, Lisa, Jansen, L, Shabli, S, Arolt, C, Quaas, A, Klussmann, J P, Mayer, M, Wolber, P

“…Primary salivary gland carcinomas (SGC) are rare neoplasms that present therapeutic challenges especially in recurrent tumors. The aim of this study was to…”
Get full text

The sharp exponent in the study of the nonlocal Hénon equation in RN: a Liouville theorem and an existence result by Barrios, B., Quaas, A.

“…We consider the nonlocal Hénon equation ( - Δ ) s u = | x | α u p , R N , where ( - Δ ) s is the fractional Laplacian operator with 0 < s < 1 , - 2 s < α , p >…”
Get full text

Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany by Nachtsheim, Lisa, Mayer, M., Meyer, M. F., Oesterling, F., Kajueter, H., Arolt, C., Quaas, A., Klussmann, J. P., Wolber, P.

“…Purpose The aim of this project was to provide an overview of the epidemiology of primary salivary gland carcinomas (SGC) in terms of incidence, distribution…”
Get full text

Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task Force by Özdemir, B.C., Oertelt-Prigione, S., Adjei, A.A., Borchmann, S., Haanen, J.B., Letsch, A., Mir, O., Quaas, A., Verhoeven, R.H.A., Wagner, A.D.

Get full text

Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer by Damanakis, A. I., Gebauer, F., Stapper, A., Schlößer, H. A., Ghadimi, M., Schmidt, T., Schiffmann, L. M., Fuchs, H., Zander, T., Quaas, A., Bruns, C. J., Schroeder, W.

“…Background Histopathologic regression following neoadjuvant treatment (NT) of oesophageal cancer is a prognostic factor of survival, but the nodal status is…”
Get full text

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial by Nilsson, K., Klevebro, F., Sunde, B., Rouvelas, I., Lindblad, M., Szabo, E., Halldestam, I., Smedh, U., Wallner, B., Johansson, J., Johnsen, G., Aahlin, E.K., Johannessen, H.-O., Alexandersson von Döbeln, G., Hjortland, G.O., Wang, N., Shang, Y., Borg, D., Quaas, A., Bartella, I., Bruns, C., Schröder, W., Nilsson, M.

“…The optimal time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer is unknown and has traditionally been 4-6 weeks in clinical…”
Get full text

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study by Hewitt, L.C., Inam, I.Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G.E., Melotte, V., Langley, R.E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G.G., Grabsch, H.I.

“…Oesophageal (OeC) and gastric (GC) cancer patients are treated with similar multimodal therapy and have poor survival. There remains an urgent clinical need to…”
Get full text

Improved Tissue Processing in Esophageal Adenocarcinoma After Ivor Lewis Esophagectomy Allows Histological Analysis of All Surgically Removed Lymph Nodes with Significant Effects on Nodal UICC Stages by Quaas, A., Schloesser, H., Fuchs, H., Zander, T., Arolt, C., Scheel, A. H., Rueschoff, J., Bruns, C., Buettner, R., Schroeder, W.

“…Background In esophageal carcinoma, the numbers of metastatic and total removed lymph nodes (LN) are well-established variables of long-term prognosis. The…”
Get full text

A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition by Schiffmann, L M, Brunold, M, Liwschitz, M, Goede, V, Loges, S, Wroblewski, M, Quaas, A, Alakus, H, Stippel, D, Bruns, C J, Hallek, M, Kashkar, H, Hacker, U T, Coutelle, O

“…Background: Vascular endothelial growth factor (VEGF)-targeting drugs normalise the tumour vasculature and improve access for chemotherapy. However, excessive…”
Get full text

Laparoscopic ischemic conditioning of the stomach prior to esophagectomy induces gastric neo-angiogenesis by Schiffmann, L.M., de Groot, E., Albert, M.C., Quaas, A., Pinto dos Santos, D., Babic, B., Fuchs, H.F., Walczak, H., Chon, S.-H., Ruurda, J.P., Kashkar, H., Bruns, C.J., Schröder, W., van Hillegersberg, R.

“…The risk of an anastomotic leakage (AL) following Ivor-Lewis esophagectomy is increased in patients with calcifications of the aorta or a stenosis of the…”
Get full text

Expression of Mucins in Different Entities of Salivary Gland Cancer: Highest Expression of Mucin-1 in Salivary Duct Carcinoma: Mucin-1 – highest expression in Salivary Duct Carcinoma by Wolber, P., Mayer, M., Nachtsheim, L., Prinz, J., Klußmann, J. P., Quaas, A., Arolt, C.

“…Therapeutic options for advanced salivary gland cancer (SGC) are rare. Therefore, it was the aim of this study to investigate the extent and intensity of…”
Get full text

Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer by Burandt, E., Jens, G., Holst, F., Jänicke, F., Müller, V., Quaas, A., Choschzick, M., Wilczak, W., Terracciano, L., Simon, R., Sauter, G., Lebeau, A.

“…AIB1 ( a mplified i n b reast cancer 1 ) is an estrogen receptorα (ERα) co-activator, known to be amplified and overexpressed in a fraction of breast cancers…”
Get full text

Progesterone supplementation for luteal phase support in non-assisted reproductive technology treatments - prevalence of use and practice patterns among infertility specialists by Weedin, E, Kort, J, Quaas, A, Baker, V.L, Hansen, K.R

Get full text

P0458 : Aggravation of liver damage in Ceacam1 (Carcinoembryonic antigen-related cell adhesion molecule 1)-deficient mice in immune mediated liver injury by Horst, A.K, Wegscheid, C, Quaas, A, Tiegs, G

Get full text

Monotonicity of solutions for some nonlocal elliptic problems in half-spaces by Barrios, B., Del Pezzo, L., García-Melián, J., Quaas, A.

“…In this paper we consider classical solutions u of the semilinear fractional problem ( - Δ ) s u = f ( u ) in R + N with u = 0 in R N \ R + N , where ( - Δ ) s…”
Get full text

The relevance of the lymph node ratio as predictor of prognosis is higher in HPV‐negative than in HPV‐positive oropharyngeal squamous cell carcinoma by Meyer, M.F., Meinrath, J., Seehawer, J., Lechner, A., Odenthal, M., Quaas, A., Semrau, R., Huebbers, C.U., Marnitz, S., Büttner, R., Beutner, D.

“…Objectives Lymph node ratio (LNR) is an established predictor in different entities of carcinoma, including head and neck malignancies. In oropharyngeal…”
Get full text

Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus by Schoemmel, M., Loeser, H., Kraemer, M., Wagener-Ryczek, S., Hillmer, A., Bruns, C., Thelen, M., Schröder, W., Zander, T., Lechner, A., Buettner, R., Schlösser, H., Gebauer, F., Quaas, A.

“…Introduction The inflammatory microenvironment has emerged as one of the focuses of cancer research. Little is known about the immune environment in esophageal…”
Get full text

Therapy susceptible germline-related BRCA 1-mutation in a case of metastasized mixed adeno-neuroendocrine carcinoma (MANEC) of the small bowel by Quaas, A, Waldschmidt, D, Alakus, H, Zander, T, Heydt, C, Goeser, T, Daheim, M, Kasper, P, Plum, P, Bruns, C, Brunn, A, Roth, W, Hartmann, N, Bunck, A, Schmidt, M, Göbel, H, Tharun, L, Buettner, R, Merkelbach-Bruse, S

“…Adenocarcinomas or combined adeno-neuroendocrine carcinomas (MANEC) of small bowel usually have a dismal prognosis with limited systemic therapy options. This…”
Get full text

Tumor microenvironment in salivary gland carcinomas: Consequences for new therapeutic concepts by Meyer, M F, Arolt, C, Kansy, B A, Doescher, J, Quaas, A, Beutner, D, Lang, S, Klußmann, J P

“…Salivary gland carcinomas (SGCs) are rare tumors which represent a challenge for diagnosis and therapy due to their histological diversity and the different…”
Get full text